Sponsored: The Evolving Role of Stem Cell Transplant in Older AML Patients

April 1, 2020
Hillard Lazarus, MD, Rajneesh Nath, MD, Alexander Perl, MD and Swaminathan Iyer, MD

Experts discuss the phase III SIERRA trial, which recently demonstrated durable complete responses in patients with acute myeloid leukemia<br /> &nbsp;

Case 1: Primary Induction Failure (PIF)

Case 2: Early Relapse with Remission <6 months

Disease State of AML

SIERRA Trial Design


Hillard M. Lazarus, MD, FACP - Case Western Reserve University

Rajneesh Nath, MD - Banner MD Anderson Cancer Center Clinic

Alexander E. Perl, MD, MS - Hospital of the University of Pennsylvania